Brady Stillman, Ph.D.

Dr. Stillman is a key consultant to ProTransit, overseeing the production of the company’s Pro-MP™ delivery technology. With extensive experience in GLP and cGMP-compliant manufacturing environments, Brady manages both pre-production and final production processes to ensure quality control and regulatory adherence. Brady is affiliated with the University of Nebraska College of Medicine, Department of Pharmacology and Experimental Neuroscience, and brings deep operational expertise from concept to clinical-grade manufacturing.